The Link between VAPB Loss of Function and Amyotrophic Lateral Sclerosis

Nica Borgese1, Nicola Iacomino1, Sara Francesca Colombo1

  • 1CNR Institute of Neuroscience, Via Follereau 3, Bldg U28, 20854 Vedano al Lambro, Italy.

Cells
|August 27, 2021
PubMed

Insights

Vesicle-associated membrane protein-associated protein B (VAPB) deficit impairs cellular functions, suggesting VAPB haploinsufficiency drives familial amyotrophic lateral sclerosis (ALS8). Further research will clarify VAPB

Area of Science:

  • Cell Biology
  • Neuroscience
  • Genetics

Background:

  • Vesicle-associated membrane protein-associated protein (VAP) proteins are endoplasmic reticulum (ER) adaptors.
  • VAPs mediate membrane contact site formation between the ER and other organelles.
  • A VAPB mutation (p.P56S) causes familial amyotrophic lateral sclerosis (ALS8).

Purpose of the Study:

  • To review studies on VAPB deficit effects in cellular and animal models.
  • To elucidate the pathogenic basis of VAPB mutations in ALS.

Main Methods:

  • Review of existing literature on VAPB deficit.
  • Analysis of cellular and animal models of VAPB deficiency.
  • Examination of phosphoinositide homeostasis, Ca2+ signaling, and ER stress.

Main Results:

  • VAPB deficit affects phosphoinositide homeostasis, Ca2+ signaling, ion transport, neurite extension, and ER stress.
  • The mutant VAPB protein is aggregation-prone, non-functional, and unstable.
  • VAPB haploinsufficiency, not toxic gain-of-function, appears to drive ALS8 pathology.

Conclusions:

  • VAPB deficit significantly impacts fundamental cellular processes.
  • VAPB haploinsufficiency is the likely driver of familial ALS8.
  • Future studies using iPSC-derived motor neurons will further elucidate ALS pathogenesis.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.8K
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
119.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
887